VALOMINDO

Modified-release tablet, 160mg + 1.5mg
RxActive license

Active substance (INN)

indapamidevalsartan

Pharmaceutical form

Pharmaceutical formModified-release tablet
Strength160mg + 1.5mg
PackagingUkupno 30 tableta sa modifikovanim oslobađanjem u blisteru (3x10) u kartonskoj kutiji
ManufacturerKrka d.d., Slovenia
Therapeutic groupCardiovascular system (C09DA03)
Marketing authorization holderDIO STRANOG DRUŠTVA "KRKA D.D. NOVO MESTO" SLOVENIJA - PREDSTAVNIŠTVO PODGORICA
Authorization dateAugust 1, 2025

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register